bokomslag Novel Anticancer Drug Protocols
Kropp & själ

Novel Anticancer Drug Protocols

John K Buolamwini Alex A Adjei

Pocket

2329:-

Funktionen begränsas av dina webbläsarinställningar (t.ex. privat läge).

Uppskattad leveranstid 10-16 arbetsdagar

Fri frakt för medlemmar vid köp för minst 249:-

Andra format:

  • 355 sidor
  • 2013
We are in an exciting era in the war against cancer, with real prospects for novel anticancer drugs that are cancer cell-specific without the toxicities that have been the hallmark of conventional cytotoxic cancer chemotherapy. Advances in cancer cell biology fueled by the molecular biology revolution have resulted in the uncovering of many novel potential molecular targets for cancer therapy. New anticancer drug discovery and development is now largely focused on exploiting these new molecular targets, which encompass oncogenes, tumor s- pressor genes, and their gene products, as well as targets involved in tumor angiogenesis, metastasis, survival, and longevity mechanisms. Exploitation of some of these targets has already yielded fruits and introduced new paradigms of molecularly targeted cancer therapy into the clinic, namely, protein kinase in- bition by antibodies or small molecules, exemplified by Herceptin (trastuzumab), a humanized antibody targeted against the HER-2 growth factor receptor tyrosine kinase for the treatment of metastatic breast cancer; and Gleevec, a small molecule bcr-abl kinase inhibitor for the treatment of chronic myel- enous leukemia.
  • Författare: John K Buolamwini, Alex A Adjei
  • Illustratör: Bibliographie 115 schwarz-weiße und 10 farbige Abbildungen
  • Format: Pocket/Paperback
  • ISBN: 9781489938398
  • Språk: Engelska
  • Antal sidor: 355
  • Utgivningsdatum: 2013-08-16
  • Förlag: Humana Press Inc.